• Explore /
  • Poster
  • / Serum IgG: A potential biomarker for predicting the efficacy of systemic therapy in metastatic renal cell carcinoma.

Serum IgG: A potential biomarker for predicting the efficacy of systemic therapy in metastatic renal cell carcinoma.

Abstract Poster

Authors

null

Honglei Cui

Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Honglei Cui , Jie Wu , Rui-Yang Xie , Gan Du , Bing-Qing Shang , Xin Dong , Yan Song , Wang Qu , Hongsong Bai , Youyan Guan , Hongzhe Shi , Xin-Gang Bi , Ai-Ping Zhou , Jianzhong Shou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 442)

DOI

10.1200/JCO.2024.42.4_suppl.442

Abstract #

442

Poster Bd #

J3

Abstract Disclosures

Similar Posters

First Author: Marine Gross-Goupil

First Author: Daniel Yick Chin Heng

Poster

2023 ASCO Genitourinary Cancers Symposium

Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021.

Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021.

First Author: John McGrane

First Author: Christine B. Peterson